Merck (MRK) Change in Cash (2009 - 2026)
Merck's (MRK) quarterly Change in Cash came in at $1.5 billion in Q2 2026, up 326.56% year-over-year from $350.0 million in Q2 2025, and up 116.07% quarter-over-quarter from -$9.3 billion in Q1 2026.
Analysis
Merck (MRK) Change in Cash (2009 - 2026) Analysis & Trends
Merck (MRK) has reported Change in Cash for 18 consecutive years, with $1.5 billion the latest figure, recorded in Q2 2026.
- On a quarterly basis, Change in Cash rose 326.56% year-over-year to $1.5 billion in Q2 2026; TTM through Jun 2026 was -$1.2 billion, a 64.18% increase from a year earlier, with the FY2025 full-year figure at $1.4 billion, down 78.59% from the prior year.
- Change in Cash was $1.5 billion for Q2 2026 at Merck, up from -$9.3 billion in the prior quarter.
- Over five years, Change in Cash peaked at $10.2 billion in Q3 2025 and troughed at -$9.3 billion in Q1 2026.
- A 5-year average of -$70.9 million and a median of -$106.0 million in 2022 frame the typical range for Change in Cash.
- Across the five-year window, Change in Cash slumped 768.23% in 2023 and surged 326.56% in 2026, its largest moves.
- Over 5 years, Change in Cash stood at $1.5 billion in 2022, then slumped by 217.8% to -$1.8 billion in 2023, then grew by 22.16% to -$1.4 billion in 2024, then slumped by 160.58% to -$3.6 billion in 2025, then soared by 141.82% to $1.5 billion in 2026.
- The last three Change in Cash figures came in at $1.5 billion (Q2 2026), -$9.3 billion (Q1 2026), and -$3.6 billion (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 650.65 Bn | 629.89 Bn | 17.26 Bn | -1.27 Bn |
| 2 | AbbVie | 466.34 Bn | 459.82 Bn | 12.70 Bn | -2.82 Bn |
| 3 | Merck | 362.11 Bn | 355.02 Bn | 12.21 Bn | 1.49 Bn |
| 4 | Novartis Ag | 267.81 Bn | 260.52 Bn | 11.24 Bn | 739.00 Mn |
| 5 | Pfizer | 157.31 Bn | 145.91 Bn | 10.94 Bn | -727.00 Mn |
| 6 | Bristol Myers Squibb | 128.75 Bn | 117.69 Bn | 9.25 Bn | -861.00 Mn |
| 7 | Sanofi | 51.80 Bn | 44.84 Bn | 10.79 Bn | 929.89 Mn |
| 8 | Revolution Medicines | 40.91 Bn | 40.91 Bn | - | 374.50 Mn |
| 9 | BeOne Medicines | 39.65 Bn | 34.55 Bn | 1.53 Bn | 427.25 Mn |
| 10 | Incyte | 25.18 Bn | 20.65 Bn | 1.57 Bn | 521.24 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.49 Bn |
| Mar 31, 2026 | -9.29 Bn |
| Dec 31, 2025 | -3.57 Bn |
| Sep 30, 2025 | 10.19 Bn |
| Jun 30, 2025 | -659.00 Mn |
| Mar 31, 2025 | -4.59 Bn |
| Dec 31, 2024 | -1.37 Bn |
| Sep 30, 2024 | 3.32 Bn |
| Jun 30, 2024 | 5.70 Bn |
| Mar 31, 2024 | -1.24 Bn |
| Dec 31, 2023 | -1.76 Bn |
| Sep 30, 2023 | 2.96 Bn |
| Jun 30, 2023 | -4.07 Bn |
| Mar 31, 2023 | -2.99 Bn |
| Dec 31, 2022 | 1.49 Bn |
| Sep 30, 2022 | 1.53 Bn |
| Jun 30, 2022 | 1.14 Bn |
| Mar 31, 2022 | 447.00 Mn |
| Dec 31, 2021 | -1.88 Bn |
| Sep 30, 2021 | 1.42 Bn |